Commodore Capital as of Dec. 31, 2025
Portfolio Holdings for Commodore Capital
Commodore Capital holds 33 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Relay Therapeutics (RLAY) | 9.6 | $144M | 17M | 8.46 | |
| Alkermes SHS (ALKS) | 6.6 | $99M | 3.6M | 27.98 | |
| Tyra Biosciences (TYRA) | 5.9 | $89M | 3.4M | 26.29 | |
| Xenon Pharmaceuticals (XENE) | 5.4 | $81M | 1.8M | 44.82 | |
| Spyre Therapeutics Com New (SYRE) | 5.2 | $78M | 2.4M | 32.76 | |
| Cogent Biosciences (COGT) | 5.2 | $78M | 2.2M | 35.52 | |
| Enliven Therapeutics (ELVN) | 4.8 | $72M | 4.7M | 15.40 | |
| Celldex Therapeutics Com New (CLDX) | 4.6 | $70M | 2.6M | 27.16 | |
| Amylyx Pharmaceuticals (AMLX) | 4.5 | $68M | 5.7M | 12.08 | |
| Terns Pharmaceuticals (TERN) | 4.0 | $60M | 1.5M | 40.40 | |
| Kymera Therapeutics (KYMR) | 3.9 | $58M | 750k | 77.81 | |
| Soleno Therapeutics (SLNO) | 3.7 | $56M | 1.2M | 46.30 | |
| Nuvalent Inc-a (NUVL) | 3.7 | $55M | 550k | 100.59 | |
| Oruka Therapeutics (ORKA) | 3.5 | $53M | 1.8M | 30.31 | |
| Pharvaris N V (PHVS) | 3.5 | $52M | 1.9M | 27.75 | |
| Nurix Therapeutics (NRIX) | 2.9 | $43M | 2.3M | 18.97 | |
| Protagonist Therapeutics (PTGX) | 2.6 | $39M | 450k | 87.34 | |
| Assembly Biosciences Com New (ASMB) | 2.3 | $34M | 1.0M | 34.01 | |
| Lb Pharmaceuticals Com Shs (LBRX) | 2.2 | $33M | 1.5M | 22.26 | |
| Cytomx Therapeutics (CTMX) | 2.2 | $33M | 7.7M | 4.26 | |
| Alto Neuroscience Com Shs (ANRO) | 2.2 | $33M | 1.8M | 17.80 | |
| Palisade Bio (PALI) | 1.8 | $27M | 11M | 2.35 | |
| Mind Medicine Mindmed Com New (MNMD) | 1.8 | $27M | 2.0M | 13.39 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.7 | $25M | 1.0M | 25.01 | |
| Pepgen (PEPG) | 1.5 | $22M | 3.4M | 6.51 | |
| Sab Biotherapeutics Com New (SABS) | 1.1 | $17M | 4.4M | 3.74 | |
| Replimune Group (REPL) | 0.9 | $14M | 1.4M | 9.72 | |
| Inhibikase Therapeutics Com New (IKT) | 0.7 | $11M | 5.4M | 2.05 | |
| Contineum Therapeutics Cl A (CTNM) | 0.6 | $9.3M | 816k | 11.43 | |
| Avalo Therapeutics Com New (AVTX) | 0.6 | $8.8M | 483k | 18.16 | |
| Rapt Therapeutics Com New (RAPT) | 0.6 | $8.5M | 250k | 33.87 | |
| Athira Pharma | 0.2 | $3.5M | 464k | 7.57 | |
| Bright Minds Biosciences Com New (DRUG) | 0.1 | $1.5M | 19k | 78.04 |
